BMJ 1998-04-25

Leukotriene modifiers in the treatment of asthma. Look promising across the board of asthma severity.

A Sampson, S Holgate

文献索引：BMJ 316(7140) , 1257-8, (1998)

全文：HTML全文

摘要

相关化合物

  • FPL 55712
  • Veliflapon

相关文献：

Strategies in the design of peptidoleukotriene antagonists.

1993-01-01

[J. Lipid Mediat. 6(1-3) , 265-73, (1993)]

Leukotriene receptor blockade in experimental heart failure.

1997-01-01

[Res. Exp. Med. (Berl.) 197(4) , 177-87, (1997)]

Leukotriene cysLT1 (LTD4) receptor antagonism of H1-antihistamines: an in vitro study.

1997-03-01

[Inflamm. Res. 46 Suppl 1 , S93-4, (1997)]

Effects of atropine, acetylsalicylic acid, FPL 55712, and phentolamine on increased histamine responsiveness of cat lung strips under conditions of airway inflammation.

1989-06-01

[Eur. Respir. J. 2(6) , 517-21, (1989)]

In vitro effect of DP-1904, a novel anti-asthma agent, against antigen-induced constriction and TXB2 release from the isolated guinea-pig lung parenchymal tissue.

1998-08-01

[Pharmacol. Res. 38(2) , 141-7, (1998)]

更多文献...